Zhitao Ying

A safe and potent anti-CD19 CAR T cell therapy

Zhitao Ying, Xue F. Huang, Xiaoyu Xiang et al. · Nature Medicine · 2019 · 435 citations · Full text

Cell Therapy, Immunology, Autoimmunity +2

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 185 citations · Full text

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

Zhitao Ying, Ting He, Xiaopei Wang et al. · Molecular Therapy — Oncolytics · 2019 · 163 citations · Full text

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China

Zhitao Ying, Haiyan Yang, Ye Guo et al. · Cancer Medicine · 2020 · 98 citations · Full text

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

Lijuan Deng, Yuqin Song, Ken H. Young et al. · Oncotarget · 2015 · 95 citations · Full text